How adaptable manufacturing models are paving a steady path into an unpredictable future
An interview with Joe Principe (Patheon), discussing the new set of “must-haves” that are emerging from the increased need for flexibility in outsourced manufacturing partnerships.
sponsored by Patheon
Pharmaceutical companies around the world are under tremendous pressure to reduce drug costs; regulators, legislators, payers, and patients are all demanding that action be taken. Now more than ever, pharmaceutical execs are re-evaluating their traditional commercial manufacturing models in order to stay competitive and meet their financial targets.
Join Rich Whitworth, Content Director, the Medicine Maker, in an interview with Joe Principe, VP of Strategic Partnerships, Patheon, discussing the new set of “must-haves” that are emerging from the increased need for flexibility in outsourced manufacturing partnerships.
Learning Objectives
- Industry trends for bringing new products to market – pricing pressures, capital costs, and regulatory challenges.
- Demand forecasting and commercial manufacturing planning – when to insource and when to outsource.
- New outsourcing business models to consider for new product launches.
